NewAmsterdam Pharma Company
NAMS
#4441
Rank
NZ$4.62 B
Marketcap
NZ$39.60
Share price
0.40%
Change (1 day)
-14.08%
Change (1 year)

Quarterly Reports (10-Q)

Latest form 10-Q quarterly reports for NewAmsterdam Pharma Company CIK: 0001936258

Thumbnail NewAmsterdam Pharma Company 10-Q Quarterly Report FY2026

10-Q Quarterly Report FY2026 Q2

Language: English

Quarterly Reports (10-Q)
Thumbnail NewAmsterdam Pharma Company 10-Q Quarterly Report FY2026

10-Q Quarterly Report FY2026 Q1

Language: English

Quarterly Reports (10-Q)
Thumbnail NewAmsterdam Pharma Company 10-Q Quarterly Report FY2025

10-Q Quarterly Report FY2025 Q3

Language: English

Quarterly Reports (10-Q)
Thumbnail NewAmsterdam Pharma Company 10-Q Quarterly Report FY2025

10-Q Quarterly Report FY2025 Q2

Language: English

Quarterly Reports (10-Q)
Thumbnail NewAmsterdam Pharma Company 10-Q Quarterly Report FY2025

10-Q Quarterly Report FY2025 Q1

Language: English

Quarterly Reports (10-Q)
Thumbnail NewAmsterdam Pharma Company 10-Q Quarterly Report FY2024

10-Q Quarterly Report FY2024 Q3

Language: English

Quarterly Reports (10-Q)
Thumbnail NewAmsterdam Pharma Company 10-Q Quarterly Report FY2024

10-Q Quarterly Report FY2024 Q2

Language: English

Quarterly Reports (10-Q)
Thumbnail NewAmsterdam Pharma Company 10-Q Quarterly Report FY2024

10-Q Quarterly Report FY2024 Q1

Language: English

Quarterly Reports (10-Q)